NR4A2 Polyclonal Antibody

This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. The encoded protein may act as a transcription factor. Mutations in this gene have been associated with disorders related to dopaminergic dysfunction, including Parkinson disease, schizophernia, and manic depression. Misregulation of this gene may be associated with rheumatoid arthritis. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.

The NR4A2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of NR4A2 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards NR4A2.

NR4A2, also known as Nurr1, is a nuclear receptor that plays a crucial role in the development and maintenance of dopaminergic neurons. It is involved in the regulation of various biological processes, including cell differentiation, apoptosis, and inflammation. Dysregulation of NR4A2 has been implicated in several neurodegenerative disorders, making it an important target for research and therapeutic interventions.

The NR4A2 Polyclonal Antibody exhibits excellent performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It recognizes endogenous levels of NR4A2 protein in a wide range of species, including human, mouse, and rat. This antibody demonstrates minimal cross-reactivity with other related proteins, ensuring accurate and reliable results.

With its high sensitivity and specificity, the NR4A2 Polyclonal Antibody is an invaluable tool for researchers studying the role of NR4A2 in neurobiology and neurodegenerative diseases. Its superior performance and versatility make it an ideal choice for both basic research and clinical applications.